DK156825C - Analogifremgangsmaade til fremstilling af en basisk ether eller et farmaceutisk acceptabelt syreadditionssalt eller kvaternaert salt deraf - Google Patents

Analogifremgangsmaade til fremstilling af en basisk ether eller et farmaceutisk acceptabelt syreadditionssalt eller kvaternaert salt deraf

Info

Publication number
DK156825C
DK156825C DK528980A DK528980A DK156825C DK 156825 C DK156825 C DK 156825C DK 528980 A DK528980 A DK 528980A DK 528980 A DK528980 A DK 528980A DK 156825 C DK156825 C DK 156825C
Authority
DK
Denmark
Prior art keywords
preparing
acid addition
acceptable acid
salt
pharmaceutical acceptable
Prior art date
Application number
DK528980A
Other languages
Danish (da)
English (en)
Other versions
DK528980A (da
DK156825B (da
Inventor
Zoltan Budai
Laszlo Magdanyi
Aranka Lay
Tibor Mezei
Katalin Grasser
Lujza Petoecz
Ibolya Kosoczky
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of DK528980A publication Critical patent/DK528980A/da
Publication of DK156825B publication Critical patent/DK156825B/da
Application granted granted Critical
Publication of DK156825C publication Critical patent/DK156825C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
DK528980A 1979-12-14 1980-12-11 Analogifremgangsmaade til fremstilling af en basisk ether eller et farmaceutisk acceptabelt syreadditionssalt eller kvaternaert salt deraf DK156825C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU79EE2715A HU179164B (en) 1979-12-14 1979-12-14 Process for producing cycloalkyl-ethers of alkanolamines
HUEE002715 1979-12-14

Publications (3)

Publication Number Publication Date
DK528980A DK528980A (da) 1981-06-15
DK156825B DK156825B (da) 1989-10-09
DK156825C true DK156825C (da) 1990-03-12

Family

ID=10995882

Family Applications (1)

Application Number Title Priority Date Filing Date
DK528980A DK156825C (da) 1979-12-14 1980-12-11 Analogifremgangsmaade til fremstilling af en basisk ether eller et farmaceutisk acceptabelt syreadditionssalt eller kvaternaert salt deraf

Country Status (27)

Country Link
US (1) US4342762A (sv)
JP (1) JPS56123953A (sv)
AT (1) AT374449B (sv)
AU (1) AU539173B2 (sv)
BE (1) BE886579A (sv)
CA (1) CA1155115A (sv)
CH (1) CH649986A5 (sv)
CS (1) CS216544B2 (sv)
DD (1) DD155320A5 (sv)
DE (1) DE3047142C2 (sv)
DK (1) DK156825C (sv)
ES (1) ES8200857A1 (sv)
FI (1) FI76783C (sv)
FR (1) FR2471968B1 (sv)
GB (1) GB2065122B (sv)
GR (1) GR72509B (sv)
HU (1) HU179164B (sv)
IE (1) IE51733B1 (sv)
IL (1) IL61685A (sv)
IT (1) IT1209377B (sv)
NL (1) NL193907C (sv)
NO (1) NO150638C (sv)
PL (1) PL127036B1 (sv)
SE (1) SE451132B (sv)
SU (1) SU1253425A3 (sv)
UA (1) UA5566A1 (sv)
YU (1) YU42367B (sv)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212188A (en) * 1992-03-02 1993-05-18 R. J. Reynolds Tabacco Company Method for treatment of neurodegenerative diseases
US5242934A (en) * 1992-03-02 1993-09-07 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5242935A (en) * 1992-03-06 1993-09-07 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5288872A (en) * 1992-03-13 1994-02-22 Wake Forest University Compounds for treatment of neurodegenerative diseases
US5227385A (en) * 1992-03-13 1993-07-13 Wake Forest University Method for treatment of neurodegenerative diseases
US5214060A (en) * 1992-04-10 1993-05-25 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5276043A (en) * 1992-04-10 1994-01-04 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5187169A (en) * 1992-04-10 1993-02-16 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5232932A (en) * 1992-05-21 1993-08-03 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5242916A (en) * 1992-07-07 1993-09-07 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
US5248690A (en) * 1992-07-07 1993-09-28 R. J. Reynolds Tobacco Company Method for treatment of neurodegenerative diseases
JPH0626170A (ja) * 1992-07-09 1994-02-01 Yodogawa Steel Works Ltd 壁板材の取付構造
JPH06193226A (ja) * 1992-12-26 1994-07-12 Yodogawa Steel Works Ltd 壁板材の取付構造
KR100381558B1 (ko) * 1994-07-01 2003-08-19 에지스 지오기스제르기아르 알티. 약제조성물및이의제조방법
US5652270A (en) * 1994-07-01 1997-07-29 Egis Gyogyszergyar Rt Pharmaceutical compositions containing bicycloheptane ether amines and a process for the preparation thereof
HU214588B (hu) 1994-07-01 1998-04-28 EGIS Gyógyszergyár Rt. Eljárás bicikloheptán-származékot tartalmazó, CCK-rendszer gátló hatású gyógyászati készítmények előállítására
US5583140A (en) * 1995-05-17 1996-12-10 Bencherif; Merouane Pharmaceutical compositions for the treatment of central nervous system disorders
HU226061B1 (en) * 1996-10-17 2008-04-28 Egis Gyogyszergyar Nyilvanosan 1,7,7-trimethyl-bicyclo[2.2.1]heptane derivative, pharmaceutical compositions containing the same and process for their preparation
HUP9900445A2 (hu) * 1999-02-24 2001-06-28 EGIS Gyógyszergyár Rt. Eljárás (1R,2S,4R)-(-)-N,N-(dimetilamino-etoxi)-2-fenil-1,7,7-trimetil-biciklo[2.2.1]heptán előállítására és ennek köztiterméke
HU227114B1 (en) * 1999-05-11 2010-07-28 Egis Gyogyszergyar Nyilvanosan (1r, 2s, 4r)-(-)-2-[n,n-(dimethylamino-ethoxy)]-2-phenyl-1,7,7-trimethyl-bicyclo[2.2.1]heptane of high purity and pharmaceutically acceptable acid addition salts thereof, process for preparation of them and medicaments containing the same
FI20002612A0 (sv) * 2000-11-28 2000-11-28 Orion Yhtymae Oyj Kombinationsterapi för vård av störningar i serotoninomsättningen
US6335372B1 (en) * 2000-11-28 2002-01-01 Orion Corporation Treatment of obsessive compulsive disorder
HUP0103017A3 (en) * 2001-07-18 2004-05-28 Egis Gyogyszergyar Nyilvanosan Pharmaceutical composition for the treatment of diseases caused by impairment of cognitive functions and its use
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
US20040192754A1 (en) * 2003-03-24 2004-09-30 Shapira Nathan Andrew Methods for treating idiopathic hyperhidrosis and associated conditions
HUP0301537A3 (en) * 2003-06-03 2005-07-28 Egis Gyogyszergyar Nyilvanosan Deramcyclane fumarate tablets and process for producing them
KR101493508B1 (ko) * 2013-02-18 2015-02-16 오스템임플란트 주식회사 치아 미백 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL246462A (sv) * 1959-08-06
DE1108684B (de) * 1960-01-29 1961-06-15 Boehringer & Soehne Gmbh Verfahren zur Herstellung neuer basischer AEther
GB895050A (en) * 1960-01-29 1962-04-26 Boehringer & Soehne Gmbh New basic ethers
AT264495B (de) * 1963-08-18 1968-09-10 Egyt Gyogyszervegyeszeti Gyar Verfahren zur Herstellung von neuen basischen Cycloheptanoläthern
GB1085969A (en) * 1965-08-11 1967-10-04 Glidden Co Insectiphobic compositions comprising terpene derivatives
US4118499A (en) * 1975-10-15 1978-10-03 Glaxo Laboratories Limited Anti-anxiety and anti-parkinsonian 1-aminoalkyl-2-endo-chloro-7,7-dimethylnorbornanes
JPS6034925B2 (ja) * 1979-07-31 1985-08-12 帝人株式会社 持続性鼻腔用製剤およびその製造法

Also Published As

Publication number Publication date
SE451132B (sv) 1987-09-07
FI76783C (sv) 1988-12-12
FI803858L (fi) 1981-06-15
PL127036B1 (en) 1983-09-30
AT374449B (de) 1984-04-25
DE3047142C2 (de) 1985-09-26
DK528980A (da) 1981-06-15
GB2065122A (en) 1981-06-24
UA5566A1 (uk) 1994-12-28
NO150638B (no) 1984-08-13
IE802612L (en) 1981-06-14
JPS56123953A (en) 1981-09-29
AU6529380A (en) 1981-06-18
IT8026587A0 (it) 1980-12-12
ATA601380A (de) 1983-09-15
NL193907B (nl) 2000-10-02
FR2471968B1 (fr) 1986-08-22
ES497717A0 (es) 1981-11-16
SE8008680L (sv) 1981-06-15
GR72509B (sv) 1983-11-16
AU539173B2 (en) 1984-09-13
DD155320A5 (de) 1982-06-02
NL193907C (nl) 2001-02-05
SU1253425A3 (ru) 1986-08-23
CH649986A5 (de) 1985-06-28
PL228392A1 (sv) 1981-08-07
US4342762A (en) 1982-08-03
IT1209377B (it) 1989-07-16
HU179164B (en) 1982-08-28
CS216544B2 (en) 1982-11-26
YU311180A (en) 1983-10-31
IE51733B1 (en) 1987-03-18
YU42367B (en) 1988-08-31
IL61685A (en) 1984-10-31
FR2471968A1 (fr) 1981-06-26
GB2065122B (en) 1983-06-29
NO150638C (no) 1984-11-21
FI76783B (fi) 1988-08-31
NO803764L (no) 1981-06-15
NL8006722A (nl) 1981-07-16
CA1155115A (en) 1983-10-11
DK156825B (da) 1989-10-09
IL61685A0 (en) 1981-01-30
ES8200857A1 (es) 1981-11-16
JPS6314703B2 (sv) 1988-04-01
BE886579A (fr) 1981-06-10
DE3047142A1 (de) 1981-09-10

Similar Documents

Publication Publication Date Title
DK156825C (da) Analogifremgangsmaade til fremstilling af en basisk ether eller et farmaceutisk acceptabelt syreadditionssalt eller kvaternaert salt deraf
DK74282A (da) Fremgangsmaade til fremstilling af imidazodiazepiner eller farmaceutisk acceptable syreadditionssalte deraf
DK151884C (da) Analogifremgangsmaade til fremstilling af 3-(1-imidazolylalkyl)indolderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK149942C (da) Fremgangsmaade til fremstilling af en pasteurellose-vaccine
DK43279A (da) Fremgangsmaade til fremstilling af 2-penem-3-carboxylsyreforbindelser
DK147362C (da) Analogifremgangsmaade til fremstilling af ergolen- eller ergolin-derivater eller syreadditionssalte deraf
DK153440C (da) Fremgangsmaade til fremstilling af et nasalt farmaceutisk ergotpeptidalkaloid-praeparat
DK528879A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende isosorbiddinitrat
DK149336C (da) Fremgangsmaade til fremstilling af antibiotikum a/16686 eller syreadditionssalte deraf
DK149569C (da) Analogifremgangsmaade til fremstilling af isoquinolineddikesyre-forbindelser eller farmaceutisk acceptable salte deraf
DK157862C (da) Analogifremgangsmaade til fremstilling af imidazolylphenylamidiner eller farmaceutisk acceptable syreadditionssalte deraf
DK160045C (da) Analogifremgangsmaade til fremstilling af 4-oxo-4h-pyridooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere ammoniumsalte deraf
DK323780A (da) Fremgangsmaade til fremstilling af substituerede 3-amino-sydnonimider eller farmakologisk acceptable syreadditionssalte deraf
DK302880A (da) Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende en 3-amino1-aryl-2-pyrazolin
DK8080A (da) Fremgangsmaade til fremstilling af en graneleret formulering af nabilon
DK158658C (da) Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf
DK396880A (da) Fremgangsmaade til fremstilling af cyclohexancarboxylsyrederivater
DK203879A (da) Fremgangsmaade til fremstilling af en farmaceutisk doseringskomponent
DK154647C (da) Analogifremgangsmaade til fremstilling af n-oe(4-oe3-substitueret 2-pyridylaapiperazino)butylaaazaspirodecanforbindelser eller et farmaceutisk acceptabelt syreadditionssalt deraf
DK7679A (da) Fremgangsmaade til fremstilling af et prostaglandinholdigt praeparat
DK149077C (da) Analogifremgangsmaade til fremstilling af encephalin-analoge pentapeptidamidderivater eller farmaceutisk acceptable syreadditionssalte deraf
DK149625C (da) Analogifremgangsmaade til fremstilling af n-substituerede (8-halogen- eller -trifluormethyl-4-quinolylamino)-benzamider eller et farmaceutiskacceptabelt syreadditionssalt deraf
DK152427C (da) Analogifremgangsmaade til fremstilling af 4-thiomethylpyridinforbindelser eller farmaceutisk acceptable syreadditionssalte deraf
DK159435C (da) Analogifremgangsmaade til fremstilling af 2-hydroxy-5-(1-hydroxy-2-piperazinylethyl)benzoesyrederivater eller et farmaceutisk acceptabelt syreadditionssalt deraf
DK162102C (da) Analogifremgangsmaade til fremstilling af 3-o-(beta-d-glucoronopyranosyl)-sojasapogenol b eller farmaceutisk acceptable salte deraf

Legal Events

Date Code Title Description
PUP Patent expired